Published in Neural Plast on January 31, 2016
Behavioural biomarkers of typical Rett syndrome: moving towards early identification. Wien Med Wochenschr (2016) 0.79
Lack of Cdkl5 Disrupts the Organization of Excitatory and Inhibitory Synapses and Parvalbumin Interneurons in the Primary Visual Cortex. Front Cell Neurosci (2016) 0.77
Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology. Front Mol Neurosci (2017) 0.75
Lysine Acetylation and Deacetylation in Brain Development and Neuropathies. Genomics Proteomics Bioinformatics (2017) 0.75
Improved MECP2 Gene Therapy Extends the Survival of MeCP2-Null Mice without Apparent Toxicity after Intracisternal Delivery. Mol Ther Methods Clin Dev (2017) 0.75
Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes. Orphanet J Rare Dis (2016) 0.75
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet (1999) 22.84
MeCP2, a key contributor to neurological disease, activates and represses transcription. Science (2008) 10.11
Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol (2010) 9.01
The story of Rett syndrome: from clinic to neurobiology. Neuron (2007) 8.08
Reversal of neurological defects in a mouse model of Rett syndrome. Science (2007) 7.09
Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron (2006) 6.50
Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature (2010) 5.11
The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron (2006) 4.74
MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell (2012) 4.56
Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A (2005) 4.52
Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science (2003) 4.52
Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci (2004) 4.40
MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron (2007) 4.15
Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci (2007) 3.81
MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci (2004) 3.48
Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci U S A (2009) 3.23
A role for glia in the progression of Rett's syndrome. Nature (2011) 3.18
Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol (2010) 3.16
MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells (2010) 2.89
The role of MeCP2 in the brain. Annu Rev Cell Dev Biol (2011) 2.84
Normal development of brain circuits. Neuropsychopharmacology (2010) 2.64
The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev Cell (2002) 2.56
In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol (2014) 2.51
Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell (2003) 2.50
Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis (2005) 2.44
Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci U S A (2007) 2.27
MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr Biol (2006) 2.25
MicroRNAs potentiate neural development. Neuron (2009) 2.25
Activity-dependent neuronal signalling and autism spectrum disorder. Nature (2013) 2.23
Adult neural function requires MeCP2. Science (2011) 2.09
Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci (2010) 1.98
MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/Drosha complex. Dev Cell (2014) 1.96
Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons. Neurobiol Dis (2007) 1.90
A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet (2004) 1.88
MicroRNAs in brain development and physiology. Curr Opin Neurobiol (2009) 1.82
Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell (2013) 1.80
The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res (2004) 1.79
Control of synaptic strength, a novel function of Akt. Neuron (2003) 1.73
Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p. Genes Dev (2013) 1.70
miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells. Nat Commun (2011) 1.67
Transcriptional co-regulation of neuronal migration and laminar identity in the neocortex. Development (2012) 1.65
Neuronal migration mechanisms in development and disease. Curr Opin Neurobiol (2010) 1.64
MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome. Proc Natl Acad Sci U S A (2015) 1.63
A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Mol Cell (2003) 1.61
Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. J Med Genet (2014) 1.58
Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in an RNA interference model of methyl-CpG-binding protein 2 deficiency. J Neurosci (2009) 1.55
Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol (2005) 1.52
Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides. Nature (2015) 1.51
Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome. Proc Natl Acad Sci U S A (2014) 1.51
Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med Genet (2007) 1.49
Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS One (2008) 1.45
Rett syndrome: a complex disorder with simple roots. Nat Rev Genet (2015) 1.40
Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum Mol Genet (2011) 1.39
Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biol Psychiatry (2010) 1.36
NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2. Neuron (2012) 1.35
Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J Mol Med (Berl) (2002) 1.32
Regulation of neural progenitor cell development in the nervous system. J Neurochem (2008) 1.31
MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites. Mol Cell Biol (2010) 1.27
Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. J Cell Sci (2008) 1.26
Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome. J Neurosci (2013) 1.26
β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A (2014) 1.23
MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res (2008) 1.19
Applications of CRISPR-Cas systems in neuroscience. Nat Rev Neurosci (2015) 1.18
The Rett syndrome protein MeCP2 regulates synaptic scaling. J Neurosci (2012) 1.16
Differential distribution of the MeCP2 splice variants in the postnatal mouse brain. J Comp Neurol (2007) 1.16
MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution. Brain Dev (2005) 1.16
Rett syndrome: genes, synapses, circuits, and therapeutics. Front Psychiatry (2012) 1.14
miR-132 enhances dendritic morphogenesis, spine density, synaptic integration, and survival of newborn olfactory bulb neurons. PLoS One (2012) 1.13
Strategies for the generation of neuronal diversity in the developing central nervous system. J Neurosci (1995) 1.13
Molecular control of neurogenesis: a view from the mammalian cerebral cortex. Cold Spring Harb Perspect Biol (2012) 1.13
MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy. PLoS One (2009) 1.09
Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex. J Neurosci (2011) 1.08
Balanced X chromosome inactivation patterns in the Rett syndrome brain. Am J Med Genet (2002) 1.08
Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis. Hum Mol Genet (2007) 1.06
MeCP2: structure and function. Biochem Cell Biol (2011) 1.06
MeCP2: only 100% will do. Nat Neurosci (2012) 1.05
Phenotypic checkpoints regulate neuronal development. Trends Neurosci (2010) 1.05
Increase in phosphorylation of Akt and its downstream signaling targets and suppression of apoptosis by simvastatin after traumatic brain injury. J Neurosurg (2008) 1.04
Reversibility of functional deficits in experimental models of Rett syndrome. Biochem Soc Trans (2010) 1.03
Excitation/inhibition imbalance and impaired synaptic inhibition in hippocampal area CA3 of Mecp2 knockout mice. Hippocampus (2014) 1.02
Inhibition of PI3K-Akt signaling blocks exercise-mediated enhancement of adult neurogenesis and synaptic plasticity in the dentate gyrus. PLoS One (2009) 1.02
Synaptic determinants of rett syndrome. Front Synaptic Neurosci (2010) 1.02
Changing the perspective on early development of Rett syndrome. Res Dev Disabil (2013) 1.02
Isoform-specific toxicity of Mecp2 in postmitotic neurons: suppression of neurotoxicity by FoxG1. J Neurosci (2012) 1.01
MECP2 Duplication Syndrome. Mol Syndromol (2011) 0.99
Neuronal differentiation of neural precursor cells is promoted by the methyl-CpG-binding protein MeCP2. Exp Neurol (2009) 0.98
MeCP2 deficiency disrupts axonal guidance, fasciculation, and targeting by altering Semaphorin 3F function. Mol Cell Neurosci (2009) 0.98
Decitabine alters the expression of Mecp2 isoforms via dynamic DNA methylation at the Mecp2 regulatory elements in neural stem cells. Mol Autism (2013) 0.98
Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome. Hum Mol Genet (2013) 0.98
MicroRNAs in neural cell differentiation. Brain Res (2010) 0.97
Conditional deletion of Mecp2 in parvalbumin-expressing GABAergic cells results in the absence of critical period plasticity. Nat Commun (2014) 0.97
Visual evoked potentials detect cortical processing deficits in Rett syndrome. Ann Neurol (2015) 0.96
Developmental delay in Rett syndrome: data from the natural history study. J Neurodev Disord (2014) 0.95
Age of diagnosis in Rett syndrome: patterns of recognition among diagnosticians and risk factors for late diagnosis. Pediatr Neurol (2015) 0.95
Phosphatidylinositol 3-kinase signaling is involved in neurogenesis during Xenopus embryonic development. J Biol Chem (2004) 0.93
Loss of MeCP2 in Parvalbumin-and Somatostatin-Expressing Neurons in Mice Leads to Distinct Rett Syndrome-like Phenotypes. Neuron (2015) 0.89
Is birth a critical period in the pathogenesis of autism spectrum disorders? Nat Rev Neurosci (2015) 0.87
Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes. Eur J Hum Genet (2011) 0.87
MeCP2 regulates the timing of critical period plasticity that shapes functional connectivity in primary visual cortex. Proc Natl Acad Sci U S A (2015) 0.87
Altered attainment of developmental milestones influences the age of diagnosis of rett syndrome. J Child Neurol (2011) 0.87
An acetylcholine-activated microcircuit drives temporal dynamics of cortical activity. Nat Neurosci (2015) 0.99